Pharma’s GCP analytics maturity evolution: Are you set up for success?
Good clinical practice (GCP) quality risk management supports effective delivery of clinical development programs and ultimately the delivery of treatments to patients. Our white paper benchmarks the maturity for top-10 pharma companies in their use of GCP quality analytics to drive scientific decisions. Through detailed desk research and industry interviews, we shine a light on three questions:
- What is the framework used to analyze the maturity of pharma organizations and how do these pharma companies fare on the maturity scale?
- What are some of the frontier practices in organizations with high GCP analytics maturity?
- How can companies leapfrog their GCP analytics maturity?
FIGURE: Our assessment of the companies across the dimensions of the ZS GCP analytics maturity framework
default
